BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8692945)

  • 1. Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1.
    Wang HG; Takayama S; Rapp UR; Reed JC
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7063-8. PubMed ID: 8692945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-2 does not require Raf kinase activity for its death-protective function.
    Olivier R; Otter I; Monney L; Wartmann M; Borner C
    Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):75-83. PubMed ID: 9164843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2 targets the protein kinase Raf-1 to mitochondria.
    Wang HG; Rapp UR; Reed JC
    Cell; 1996 Nov; 87(4):629-38. PubMed ID: 8929532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cytokine-activated tyrosine kinase JAK2 activates Raf-1 in a p21ras-dependent manner.
    Xia K; Mukhopadhyay NK; Inhorn RC; Barber DL; Rose PE; Lee RS; Narsimhan RP; D'Andrea AD; Griffin JD; Roberts TM
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11681-6. PubMed ID: 8876196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase.
    Wang HG; Miyashita T; Takayama S; Sato T; Torigoe T; Krajewski S; Tanaka S; Hovey L; Troppmair J; Rapp UR
    Oncogene; 1994 Sep; 9(9):2751-6. PubMed ID: 8058342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. R-Ras promotes apoptosis caused by growth factor deprivation via a Bcl-2 suppressible mechanism.
    Wang HG; Millan JA; Cox AD; Der CJ; Rapp UR; Beck T; Zha H; Reed JC
    J Cell Biol; 1995 May; 129(4):1103-14. PubMed ID: 7744959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raf revealed in life-or-death decisions.
    Pritchard C; McMahon M
    Nat Genet; 1997 Jul; 16(3):214-5. PubMed ID: 9207779
    [No Abstract]   [Full Text] [Related]  

  • 8. Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity.
    Takayama S; Sato T; Krajewski S; Kochel K; Irie S; Millan JA; Reed JC
    Cell; 1995 Jan; 80(2):279-84. PubMed ID: 7834747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulatory effects of yeast and mammalian 14-3-3 proteins on the Raf protein kinase.
    Irie K; Gotoh Y; Yashar BM; Errede B; Nishida E; Matsumoto K
    Science; 1994 Sep; 265(5179):1716-9. PubMed ID: 8085159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligomerization activates c-Raf-1 through a Ras-dependent mechanism.
    Luo Z; Tzivion G; Belshaw PJ; Vavvas D; Marshall M; Avruch J
    Nature; 1996 Sep; 383(6596):181-5. PubMed ID: 8774885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site.
    Aho TL; Sandholm J; Peltola KJ; Mankonen HP; Lilly M; Koskinen PJ
    FEBS Lett; 2004 Jul; 571(1-3):43-9. PubMed ID: 15280015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of signalling proteins interacting with B-Raf in the yeast two-hybrid system.
    Papin C; Denouel A; Calothy G; Eychène A
    Oncogene; 1996 May; 12(10):2213-21. PubMed ID: 8668348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-cascade activation of ERKs and ternary complex factors by Rho family proteins.
    Frost JA; Steen H; Shapiro P; Lewis T; Ahn N; Shaw PE; Cobb MH
    EMBO J; 1997 Nov; 16(21):6426-38. PubMed ID: 9351825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tpl-2 acts in concert with Ras and Raf-1 to activate mitogen-activated protein kinase.
    Patriotis C; Makris A; Chernoff J; Tsichlis PN
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9755-9. PubMed ID: 7937886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase.
    Salmeron A; Ahmad TB; Carlile GW; Pappin D; Narsimhan RP; Ley SC
    EMBO J; 1996 Feb; 15(4):817-26. PubMed ID: 8631303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated Ras displaces 14-3-3 protein from the amino terminus of c-Raf-1.
    Rommel C; Radziwill G; Lovrić J; Noeldeke J; Heinicke T; Jones D; Aitken A; Moelling K
    Oncogene; 1996 Feb; 12(3):609-19. PubMed ID: 8637718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single amino acid change in Raf-1 inhibits Ras binding and alters Raf-1 function.
    Fabian JR; Vojtek AB; Cooper JA; Morrison DK
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5982-6. PubMed ID: 8016101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1.
    Zhang XF; Settleman J; Kyriakis JM; Takeuchi-Suzuki E; Elledge SJ; Marshall MS; Bruder JT; Rapp UR; Avruch J
    Nature; 1993 Jul; 364(6435):308-13. PubMed ID: 8332187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raf-1 forms a stable complex with Mek1 and activates Mek1 by serine phosphorylation.
    Huang W; Alessandrini A; Crews CM; Erikson RL
    Proc Natl Acad Sci U S A; 1993 Dec; 90(23):10947-51. PubMed ID: 8248196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane.
    Leevers SJ; Paterson HF; Marshall CJ
    Nature; 1994 Jun; 369(6479):411-4. PubMed ID: 8196769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.